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Abstract: The collection and dissemination of data on human and non-human organisms has 
become a central feature of 21st century biology and has been endorsed by funding agencies 
in the United States and Europe as crucial to translating biological research into therapeutic 
and agricultural innovation. Large molecular datasets, often referred to as ‘big data’, are 
increasingly incorporated into digital databases, many of which are freely accessible online. 
These data have come to be seen as resources that play a key role in mediating global market 
exchange, thus achieving a prominent social and economic status well beyond science itself. 
At the same time, calls to make all such data publicly and freely available have garnered 
strength and visibility, most prominently in the form of the Open Data movement. I discuss 
these developments by considering the conditions under which data journey across the 
communities and institutions implicated in globalized biology and biomedicine; and what this 
indicates about how internet-based communication and the use of online databases impact 
scientific research and its role within contemporary society. 
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Scientific data can be defined as material artifacts that are collected and used as empirical 
evidence for the plausibility of claims about the nature of reality (‘the earth revolves around 
the sun’) and/or the efficacy of specific interventions (‘500 milligrams of paracetamol help to 
relieve headache’). Their role as evidence for scientific claims makes them into public 
objects, which, at least in principle, can and should be widely scrutinized to assess the 
validity of the inferences drawn from them. And yet, the vast majority of scientific data 
generated in the second half of the 20th century have only been accessed by small groups of 
experts; and very few of those data, selected in relation to the inferences made by the 
scientists who analyzed them, have been made publicly available through publication in 
scientific journals. This management of data dissemination is tied to a view of scientific 
knowledge production as an esoteric and technical process, where even trained researchers 
become so specialized as to be unable to assess data produced by fields other than their own. 
Within this view, scientists invest time and effort in scrutinizing data produced by colleagues 
only when they have reason to doubt their interpretation or suspect foul play; and concerns 
with data production and interpretation, including issues associated to the emergence of ‘big 
data’ in the biological and biomedical sciences, remain remote from global civil society. 
 
Since the start of the new millennium, the Open Data movement has challenged this 
technocratic way of conceptualizing practices of data sharing and their political, social and 
economic significance. The movement brings together scientists, policy-makers, publishers, 
industry representatives and members of civil society around the globe who believe that data 
produced by scientific research should be made publicly accessible online and freely usable 
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to anyone. The internet provides a platform for scientists to exchange data, materials and 
opinions in real time, no matter where they are geographically located. Participants in the 
Open Data movement embrace this opportunity. They typically advocate that data can and 
should travel beyond the specific setting in which they are generated, because free and wide 
data dissemination enhances the chance that people who have not been involved in their 
production (whether they are scientists or not) will contribute to their interpretation. 
Accordingly, the production of scientific knowledge is portrayed as involving the centralized 
collection and ‘mining’ of datasets gathered by different research communities across the 
globe. Pooling together results, it is argued, maximises the chances of spotting significant 
patterns in the data that are collected, and thus of transforming data into knowledge (OECD 
2009, Royal Society 2012). This in turn may improve the quality, accessibility and 
transparency of research and speed up the rate of scientific discovery. Some scientists even 
refer to this shift as a new, ‘data-driven’ paradigm of research (Hey et al 2009). 
 
Whether research is actually being driven by data, rather than theories, hypotheses, models or 
policy challenges, remains disputable (Leonelli 2012a/b). What is clear is that data are 
increasingly conceptualized as inherently valuable products of scientific research, rather than 
as components of the research process which have no value in themselves. This involves 
viewing data as open to several possible interpretations, whose validity and usefulness 
depend on the questions, interests and materials characterizing the specific context in which 
data are adopted (Leonelli 2009a, 2013). It also involves viewing data as research outputs that 
can be published and cited without necessarily having been used as evidence for a specific 
claim (as required within traditional journal publications). 
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This methodological, conceptual and institutional shift in the scientific status of data is 
particularly visible within biology and biomedicine, where the emergence of ‘big data’ in the 
form of large molecular datasets (generated through new technologies such as sequencing 
machines and microarray experiments) has developed hand in hand with an ethos of data 
sharing. Indeed, the widespread sharing advocated by the Open Data movement has also long 
been supported by biologists working on key non-human organisms for molecular research, 
such as the fruit-fly Drosophila melanogaster (Kohler 1994, Leonelli and Ankeny 2012, 
Kelty 2012). Further, prominent biomedical researchers such as Francis Collins (who used to 
direct the Human Genome Project and now heads the National Institute of Health) have 
forcefully argued against the privatization of human genomic data, for instance by 
underwriting international agreements to release sequence data as soon as it is produced.1 
 
Over the last decade, funding agencies such as the National Institute of Health, National 
Science Foundation, European Research Council and Research Councils UK have strongly 
endorsed this innovative perception of how data should be managed. They are actively 
promoting Open Data as key to the advancement of basic research and its translation into 
applications with immediate social impact, such as therapeutic or agricultural innovations.2 In 
practice, this means that they are pressuring their grantees to release data to public databases 
– a move that in turn affects how scientists set up their research and how they measure and 
develop their outputs. Many researchers now invest considerable time and resources into 
donating data to public repositories; and regard the consultation of online databases as a first 
and crucial step towards the development of new lines of inquiry.  
 
                                                
1 One well-known example of such agreements are the so-called Bermuda Rules (Harvey and McMeekin 2007; 
see also ongoing research by Rachel Ankeny and Robert Cook-Deegan). 
2 These shifts in science policy are evidenced by the recommendations of the National Working Group on 
Expanding Access to Published Research Findings in the UK, also known as the Finch Report, and the 
subsequent statement by Research Councils UK, both from 2012. 
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An important question to raise vis-à-vis these scientific developments, which also helps to 
decipher their significance to global civil society at large, concerns the reasons why the Open 
Data movement has acquired such prominence in contemporary scientific and public 
discourse. Given the enormous achievements of 20th century science, where data sharing was 
confined to small sections of the (predominantly Western) scientific community, why are 
funding bodies insisting on Open Data as crucial to 21st century research? This is the central 
question that I wish to address in this paper. A standard answer to this question, often 
endorsed by journalistic accounts of the power and promise of ‘big data’, points to Open Data 
as a crucial way for scientists to exploit the emergence of new technologies, such as genome 
sequencing and internet-based social media. It is certainly true that the availability and 
widespread uptake of new information and communication technologies, as well as the 
introduction of new methods of data generation, play a crucial role in making it possible to 
produce and share information on the scale advocated by the Open Data movement. And yet, 
I believe that the emergence and political impact of the Open Data movement are not a mere 
consequence of technological advances in data production and communication, nor are its 
implications restricted solely to science.  
 
In what follows, I argue that the scientific concerns underlying the Open Data movement 
need to be evaluated in relation to at least four other sets of factors. First, Open Data provides 
a common platform for scientists, scientific institutions and funders (in both the private and 
the public sphere) to discuss and tackle the practical difficulties involved in making data 
travel and be re-used. Second, it feeds into concerns with transparency, legitimacy and return 
on investment on the part of science policy and funding bodies. Third, it aligns with the 
challenges posed by the globalization of biomedical research to new parts of the world, and 
the resulting infrastructural fragmentation and geographical dispersion of research processes. 
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And forth, it exemplifies the embedding of scientific research in market logics and contexts. 
To make it at all feasible for data to travel, market structures and political institutions need to 
assess not only their scientific value, but also their value as political, financial and social 
objects: the increased mobility of data is unavoidably tied to their commodification. Thus, not 
only does the widespread dissemination of biomedical data challenge established ways to 
produce, control and use scientific knowledge; it also plays a key role in mediating global 
market exchange and international politics, thus achieving a prominent social and economic 
significance well beyond science itself.  
 
A critical assessment of the significance of the Open Data movement for contemporary 
society at large needs to take account of all these factors, which foreground the indissoluble 
ties of scientific research to global political economy. I shall now briefly discuss each set of 
factors with reference to recent developments in biological and biomedical research.  
 
Let us start from the importance of bringing together a variety of stakeholders to tackle the 
difficulties involved in making data travel. The fact that data are produced by a variety of 
groups, for different purposes, in different parts of the world poses immense scientific, 
logistical, ethical and structural challenges to their open dissemination. Whether scientific 
data are shared, among whom and to which effect depends on the existence of appropriate 
regulatory, social and material infrastructures, such as (1) workable databases, guidelines on 
data donation, and servers located in safe locations where data storage can be guarantee in the 
long term; as well as (2) well-coordinated networks of individuals, scientific groups, 
companies and institutions that take responsibility for developing, financing and enforcing 
those infrastructures and the related instruments, computers and software (Hilgartner 1995; 
Leigh Star 1996; Bowker 2001; Hine 2006; Edwards 2010; Leonelli 2010a/b). 
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Virtually every area of biological and biomedical investigation is in need of dedicated 
databases, which are specifically targeted to collecting and visualizing the varieties of data 
involved in each field. For instance, cancer research requires the integration of genetic, 
physiological and clinical data, as well as data coming from non-human organisms such as 
mice. Providing common access to such diverse datasets is a complex requirement involving 
the coordination of several stakeholders in cancer research, ranging from individual research 
laboratories to pharmaceutical industries, governmental agencies, hospitals and public health 
services. Even well-funded attempts such as the Cancer Bioinformatics Grid have struggled 
to coordinate such an extensive and varied group.  
 
In response to the technical demands involved in these efforts, companies like IBM and 
leading universities such as Harvard and MIT are training a whole new cluster of ‘data 
scientists’ specializing in the construction of data infrastructure. Data scientists need to 
combine knowledge of specific areas of the life sciences (such as genetics or cell biology) 
with skills in bioinformatics and computer science – a new set of skills which makes the 
curation of data, hitherto seen as a technician’s job, into a branch of scientific research in its 
own right (Hilgartner 1995; Lenoir 1999; Hine 2006; Leonelli 2009b, 2010b, 2012a).  
 
However, this approach requires institutional and financial backing, in order to guarantee that 
data scientists have the status and power needed to develop and implement their 
contributions. This is hardly surprising when looking at previous examples of such efforts in 
the history of science:  there are well-documented cases of data infrastructures that were 
unable, in the longer term, to co-ordinate the diversity of interests, values, terminologies and 
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constraints involved in the relevant research areas, as well as to muster enough financial and 
human resources to support themselves.3  
 
The resources and skills required to achieve such coordination are clearly not only technical, 
but also social (Leonelli 2009b, 2010b, forthcoming). Thus, many scientific institutions are 
thus incorporating mechanisms to recognize and reward the contributions of data scientists. 
Industries are also increasingly supporting bioinformaticians as key contributors to R&D; and 
the publishing industry is trialing new types of journal devoted to documenting data 
dissemination strategies (e.g. GigaScience, started in 2012). 
 
These new infrastructures are in turn embedded within wider political and economic contexts, 
which brings me to the second set of factors underlying the current push towards Open Data: 
the emphasis placed by public institutions responsible for science funding, often under 
pressure from national and international policy, on fostering public trust in science as a 
source of reliable knowledge and thus as a legitimate source of information.  
 
Promoting the transparency and accessibility of science is particularly important in the face 
of its technical nature, which makes it hard to comprehend for the vast majority of citizens, 
and the disillusionment surrounding technoscientific achievement in the West. Cases in point 
are the controversies raging over the safety of genetically modified foods in Europe, or the 
recent criminalisation of earthquake specialists in Italy, accused of failing to predict the 2009 
devastation of the city of L’Aquila. Perhaps the most blatant recent case of public mistrust in 
science is the controversy following the public release of emails exchanged by researchers at 
the Climatic Research Unit of the University of East Anglia in 2010 (an episode often 
                                                
3 For a fascinating case of a data infrastructure whose origins date back to the 1950s and whose success has been 
marked by moments of failure and profound transformation, see the Long Term Ecological Research community 
(Anorova, Baker and Oreskes 2010; Baker and Millerand 2010). 
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referred to as ClimateGate). This was a case where a perceived lack of transparency in how 
climate data were handled fuelled social mistrust in the scientific consensus on global 
warming, which in turn affected public support for the implementation of international 
measures against climate change. Many national governments and international organisations 
like the European Research Council support the free circulation of data in the hope that it will 
increase the transparency and accountability of scientific research - and thus, potentially, its 
trustworthiness and social legitimacy. Similarly, the Royal Society has pointed to Open Data 
as an opportunity to prevent scientific fraud and disclose the evidence base for scientific 
pronouncements to the general public, so as to avoid the kind of miscommunication and 
misunderstanding underlying ClimateGate. 
  
The increasing reliance on and support for online data dissemination is also intimately related 
to the globalisation of science beyond traditional centres of Euro-American power (my third 
point). Open Data are implicated in transforming the geographies of science and its relation 
to local economies, as illustrated by the rise of centres of biomedical research excellence in 
the Global South. Centres such as the Beijing Genomics Institute, one of the powerhouses of 
contemporary data production in biomedicine, interact with researchers across the globe 
largely through digital means, and do not see themselves as requiring the support of extensive 
local or even national research infrastructure and traditions. Thanks to widespread data 
dissemination over the internet, they can quickly learn from results produced elsewhere and 
contribute their own share of data to international databases and research projects, thus 
gaining visibility and competing with established programmes in the United States, Japan and 
Europe. Nations that have not figured as prominent producers of scientific knowledge 
throughout the 20th century, such as China and Singapore, are thus devoting increasing 
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financial support to research, in the hope to attract a highly skilled workforce and boost their 
industrial productivity and economic prospects. 
 
The conditions of possibility for data sharing, and the diverse motivations, stakes and 
incentives underlying data donation to online databases, illustrate how widespread data 
dissemination has created new forms of inclusion and exclusion. One might think that 
laboratories in poor or underfunded regions would strongly support data sharing, for it makes 
data produced with expensive technology accessible to them, thus raising their chance to 
produce cutting-edge science; and that rich laboratories, which regard the possession of such 
technologies as providing them with a competitive edge, would be reluctant to donate data – 
particularly since donation requires additional labour. However, taking account of the 
considerable resources and diverse expertise needed to transform data into new knowledge 
helps to acquire a more realistic view on the benefits and costs of data sharing. Underfunded 
laboratories actually struggle to access online resources, appropriate bandwidth, adequate 
expertise and computers powerful enough to analyse data found online; and are coming to 
terms with the difficulties involved in developing resources and standards for data donation. 
By contrast, many rich laboratories have found that data donation offers the opportunity to 
participate in international networks and receive help with data analysis, thus accruing their 
own prestige, visibility and productivity. Even major pharmaceutical companies like 
GlaxoSmithKline and Syngenta are contributing to the development of public databases, in 
the hope of outsourcing their R&D efforts, improve their public image and gaining from the 
availability of data produced through public funding.  
 
This brings me to the last set of factors that I wish to discuss as relevant to explaining the 
prominence of Open Data as a contemporary social and scientific movement. This is the 
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extent to which data dissemination practices are embedded into global political economies. 
The very idea of scientific data as artefacts that can be traded, circulated across the globe 
and re-used to create new forms of value is indissolubly tied to market logics, with data 
figuring as objects of market exchange. National governments and industries that have 
invested heavily on data production – through the financing of clinical trials or genome 
sequencing projects – are keen to see results. This requirement to maximise returns from past 
investments, and the urgency typically attached to it, fuels the emphasis on data needing to 
travel widely and fast to create knowledge that would positively impact human health.  
 
This is particularly evident when considering the extraordinary expectations linked to the 
Human Genome Project and its potential to contribute to medical advances. Indeed, it could 
be argued that the allure of ‘big data’ lies precisely in the impossibility to predict and 
quantify their potential as evidence in advance. This makes it possible to inflate or deflate 
expectations to suit the dynamics of venture capitalism, while at the same time respecting the 
methods and ultimate goals of the scientific effort at hand. If we were able to predict exactly 
how a specific dataset could be used in the future, and thus which data should or not be 
widely disseminated, we would not need Open Data in the first place: the point of free and 
widespread data dissemination is that one never knows who might be able to view which data 
and see something new in them, or indeed whether such fruitful use of data is at all possible.4 
As exemplified by Mike Fortun’s 2008 analysis of the DECODE case, the opportunity to 
circulate and re-interpret data is unavoidably couched in vastly promissory terms, and it is 
hard to differentiate a priori between a fruitful data sharing initiative and one that is unlikely 
to yield scientific insight – which makes financial investments in this area both risky and 
potentially rewarding. 
                                                
4 Let us not forget that the vast majority of genomic data made available online over the last ten years have yet 
to be used in ways that are scientifically meaningful; and that some scientists view much of the data being put 
online today as pointless information, which will never be exploited despite its wide accessibility. 
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Further, the open dissemination and re-use of data does not only challenge notions of 
competition and property within established scientific communities, but also notions of 
property, privacy and effective communication in industry, government and civil society. 
Data acquired from patients in clinical trials or participants in personalised genomics, for 
instance, have clear economic value, and many pharmaceutical companies welcome the 
opportunity to access personal information unwittingly circulated by citizens who are not 
aware of its value as ‘data’ for medical research – a move widely disputed by legal scholars, 
advocacy groups and medical associations as an infringement of privacy (Tutton and 
Prainsack 2011). The dissemination of data of relevance to innovation in food security or 
bioenergy, such as molecular data on plants and plant pathogens, is similarly plagued by 
uncertainties about intellectual property, particularly in cases of public-private partnerships 
between governmental agencies and companies such as Monsanto or Shell. It is yet unclear 
how fundamentally data sharing will transform industrial practices and relations to 
intellectual property, but it is notable that such an option is being actively considered.  
 
Kaushik Sunder Rajan (2006) and Chris Kelty (2008) have shown how free data access has 
greatly helped to maximise exchange and downstream capital flows. At the same time, data 
mobility is not free in the sense of being devoid of financial and social costs. Data sharing 
requires human resources and capital: even the most successful initiatives are confronted with 
the exponential costs involved in maintaining and expanding data infrastructures in the long-
term, and are struggling to produce sustainable business plans for their activities (Bastow and 
Leonelli 2010). Indeed, the European Union has denounced the costs associated with funding 
the current plurality of online databases in biomedicine as unsustainable in the long term, and 
is pushing for the centralisation of facilities for data sharing as a possible solution (most 
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prominently through ELIXIR, a gigantic effort currently underway at the European 
Bioinformatics Institute to coordinate and eventually integrate data sharing initiatives in 
biology and medicine; see the ELIXIR website: http://www.elixir-europe.org/ ). The National 
Science Foundation, which has funded many successful data sharing initiatives at the turn of 
the millennium, is also attempting to rationalise its investments in this area and is now asking 
database curators to provide self-sustaining business models (e.g. Bastow et al 2010). 
 
To conclude: the emergence of technologies that facilitate the production and dissemination 
of biological data on a large scale is certainly a key reason for the visibility and political 
support garnered by the Open Data movement in recent years. Further, adequate expertise 
and infrastructures are needed to assess the reliability and potential significance of data, thus 
ensuring that data journeys can contribute to the development of knowledge perceived to be 
relevant and useful within a variety of domains. In turn, the development of technologies and 
expertise for the care of data, not to mention their production and use to create new 
biomedical knowledge and interventions, is made possible by the availability of institutions 
that help to define the financial value of data as commodities and the conditions under which 
data can be made to travel around the globe.  
 
What has propelled data into becoming protagonists of contemporary biomedicine is their 
ambiguous status as at once local and global, free commodities and strategic investments, 
common goods and grounds for competition, potential evidence and meaningless 
information. Openness, defined through the opportunities for dissemination associated with 
the internet, is a defining characteristic of ‘big data’ science, policy and infrastructure. The 
vision underlying the Open Data movement is that data risk to remain meaningless if they are 
prevented from travelling far and wide, and that travel endows data with multiple forms of 
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scientific as well as financial, social and political value. This flexibility to multiple uses and 
future scenarios, as well as to the diverging interests of potential users, is crucial to a 
contemporary biomedicine that is concerned with movement, and which sees the constant re-
articulations of knowledge to and through value.5 
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